Ronald M. Krauss, Jonathan T. Lu, Joseph J. Higgins, Cathryn M. Clary, & Ray Tabibiazar. (2023). VLDL receptor gene therapy for reducing atherogenic lipoproteins. Elsevier.
Chicago Style (17th ed.) CitationRonald M. Krauss, Jonathan T. Lu, Joseph J. Higgins, Cathryn M. Clary, and Ray Tabibiazar. VLDL Receptor Gene Therapy for Reducing Atherogenic Lipoproteins. Elsevier, 2023.
MLA (9th ed.) CitationRonald M. Krauss, et al. VLDL Receptor Gene Therapy for Reducing Atherogenic Lipoproteins. Elsevier, 2023.
Warning: These citations may not always be 100% accurate.